Oops




$2.4T
Total marketcap
$81.6B
Total volume
BTC 50.86%   •   ETH 15.58%
Dominance

China Resources Double-Crane Pharmaceutical Co.,Ltd. 600062.SS Stock

21.2 CNY {{ price }} -0.841901% {{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Drug Manufacturers-Specialty & Generic
COUNTRY
China
Exchange
Shanghai
Market Cap
21.11B CNY
LOW - HIGH [24H]
19.21 - 20.3 CNY
VOLUME [24H]
12.54M CNY
{{ volume }}
P/E Ratio
15.61
Earnings per share
1.3 CNY

China Resources Double-Crane Pharmaceutical Co.,Ltd. Price Chart

China Resources Double-Crane Pharmaceutical Co.,Ltd. 600062.SS Financial and Trading Overview

China Resources Double-Crane Pharmaceutical Co.,Ltd. stock price 21.2 CNY
Previous Close 17.28 CNY
Open 17.35 CNY
Bid 17.51 CNY x N/A
Ask 17.52 CNY x N/A
Day's Range 17.35 - 17.62 CNY
52 Week Range 16.02 - 32.85 CNY
Volume 12.07M CNY
Avg. Volume 20.32M CNY
Market Cap 18.27B CNY
Beta (5Y Monthly) 0.05722
PE Ratio (TTM) 14.965813
EPS (TTM) 1.3 CNY
Forward Dividend & Yield 0.77 (4.47%)
Ex-Dividend Date September 28, 2022
1y Target Est 24.32 CNY

600062.SS Valuation Measures

Enterprise Value 15.96B CNY
Trailing P/E 14.965813
Forward P/E 12.075862
PEG Ratio (5 yr expected) 0.68
Price/Sales (ttm) 1.8893509
Price/Book (mrq) 1.7490761
Enterprise Value/Revenue 1.651
Enterprise Value/EBITDA 9.001

Trading Information

China Resources Double-Crane Pharmaceutical Co.,Ltd. Stock Price History

Beta (5Y Monthly) 0.05722
52-Week Change -20.77%
S&P500 52-Week Change 20.43%
52 Week High 32.85 CNY
52 Week Low 16.02 CNY
50-Day Moving Average 18.7 CNY
200-Day Moving Average 18.91 CNY

600062.SS Share Statistics

Avg. Volume (3 month) 20.32M CNY
Avg. Daily Volume (10-Days) 12.14M CNY
Shares Outstanding 1.04B
Float 409.8M
Short Ratio N/A
% Held by Insiders 61.74%
% Held by Institutions 1.27%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.578
Trailing Annual Dividend Yield 3.34%
5 Year Average Dividend Yield 217.00%
Payout Ratio 0.65839994
Last Split Factor 1.2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 12.45%
Operating Margin (ttm) 12.82%
Gross Margin 54.75%
EBITDA Margin 18.34%

Management Effectiveness

Return on Assets (ttm) 5.44%
Return on Equity (ttm) 11.55%

Income Statement

Revenue (ttm) 9.67B CNY
Revenue Per Share (ttm) 9.38 CNY
Quarterly Revenue Growth (yoy) 8.79%
Gross Profit (ttm) N/A
EBITDA 1.77B CNY
Net Income Avi to Common (ttm) 1.2B CNY
Diluted EPS (ttm) 1.17
Quarterly Earnings Growth (yoy) 12.19%

Balance Sheet

Total Cash (mrq) 2.85B CNY
Total Cash Per Share (mrq) 2.74 CNY
Total Debt (mrq) 263.28M CNY
Total Debt/Equity (mrq) 2.37 CNY
Current Ratio (mrq) 2.581
Book Value Per Share (mrq) 10.011

Cash Flow Statement

Operating Cash Flow (ttm) 1.28B CNY
Levered Free Cash Flow (ttm) 438.52M CNY

Profile of China Resources Double-Crane Pharmaceutical Co.,Ltd.

Country China
State N/A
City Beijing
Address No. 1, Lize East 2nd Road
ZIP 100102
Phone 86 10 6439 9092
Website https://www.dcpc.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 11821

China Resources Double-Crane Pharmaceutical Co.,Ltd., together with its subsidiaries, operates as a pharmaceutical company in the People's Republic of China. The company offers soft bag, plastic and glass bottle, inner sealed polypropylene, and polypropylene blend bag infusion products; levofloxacin methylate, ambroxol hydrochloride glucose, fructose, invert sugar, hydroxyethyl starch, sodium chloride injection products, etc.; and peritoneal dialysate, hemodialysis dialysate, etc. It also provides compound reserpine triamterene tablets, pitavastatin calcium tablets, telmisartan capsules, suppository capsules, banidipine hydrochloric acid sustained-release capsules, edaravone, and other products to treat cardiovascular and cerebrovascular diseases. In addition, the company offers products for endocrinology; and pediatric compound amino acid injection, and other drugs to treat pediatrics. Further, it provides nutritional drugs, including vitamin E and C; and anti-infective drugs. The company is headquartered in Beijing, the People's Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. is a subsidiary of Beijing Pharmaceutical Group Co., Ltd.

Q&A For China Resources Double-Crane Pharmaceutical Co.,Ltd. Stock

What is a current 600062.SS stock price?

China Resources Double-Crane Pharmaceutical Co.,Ltd. 600062.SS stock price today per share is 21.2 CNY.

How to purchase China Resources Double-Crane Pharmaceutical Co.,Ltd. stock?

You can buy 600062.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for China Resources Double-Crane Pharmaceutical Co.,Ltd.?

The stock symbol or ticker of China Resources Double-Crane Pharmaceutical Co.,Ltd. is 600062.SS.

Which industry does the China Resources Double-Crane Pharmaceutical Co.,Ltd. company belong to?

The China Resources Double-Crane Pharmaceutical Co.,Ltd. industry is Drug Manufacturers-Specialty & Generic.

How many shares does China Resources Double-Crane Pharmaceutical Co.,Ltd. have in circulation?

The max supply of China Resources Double-Crane Pharmaceutical Co.,Ltd. shares is 995.52M.

What is China Resources Double-Crane Pharmaceutical Co.,Ltd. Price to Earnings Ratio (PE Ratio)?

China Resources Double-Crane Pharmaceutical Co.,Ltd. PE Ratio is 15.61538500 now.

What was China Resources Double-Crane Pharmaceutical Co.,Ltd. earnings per share over the trailing 12 months (TTM)?

China Resources Double-Crane Pharmaceutical Co.,Ltd. EPS is 1.3 CNY over the trailing 12 months.

Which sector does the China Resources Double-Crane Pharmaceutical Co.,Ltd. company belong to?

The China Resources Double-Crane Pharmaceutical Co.,Ltd. sector is Healthcare.

Stocks Related By Sector

Stocks Related By Industry

Stocks Related By Marketcap